Research Frontiers, Inc. (REFR) At $1.05 Forms Bottom; Cvsl (NYSEAMERICAN:JRJR) Shorts Decreased By 51.74%

November 15, 2017 - By Stephen Andrade

Research Frontiers, Inc. (REFR) formed multiple bottom with $1.02 target or 3.00% below today’s $1.05 share price. Research Frontiers, Inc. (REFR) has $25.25 million valuation. The stock decreased 5.41%

or $0.06 on November 14, reaching $1.05. About shares traded. Research Frontiers, Inc. (NASDAQ:REFR) has declined 72.08% since November 15, 2016 and is downtrending. It has underperformed by 88.78% the S&P500.

Cvsl Incorporated (NYSEAMERICAN:JRJR) had a decrease of 51.74% in short interest. JRJR’s SI was 26,400 shares in November as released by FINRA. Its down 51.74% from 54,700 shares previously. With 337,500 avg volume, 0 days are for Cvsl Incorporated (NYSEAMERICAN:JRJR)’s short sellers to cover JRJR’s short positions. The SI to Cvsl Incorporated’s float is 0.15%. The stock decreased 2.78% or $0.005 on November 14, reaching $0.175. About shares traded. JRjr33 Inc (NYSEAMERICAN:JRJR) has declined 51.12% since November 15, 2016 and is downtrending. It has underperformed by 67.82% the S&P500.

JRjr33, Inc. , formerly CVSL Inc., offers a platform of direct-to-consumer brands. The company has market cap of $7.10 million. The Firm operates through the divisions, which include Gourmet Food, Nutritional and Wellness, Home Decor, Publishing and Printing, and Other. It currently has negative earnings. The Gourmet Food Products segment consists of activities related to the production and sale of hand-crafted spices, oils and other food products from around the world.

Among 3 analysts covering Research Frontiers (NASDAQ:REFR), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Research Frontiers has $6 highest and $400 lowest target. $5.25’s average target is 400.00% above currents $1.05 stock price. Research Frontiers had 4 analyst reports since August 12, 2015 according to SRatingsIntel. As per Wednesday, August 12, the company rating was upgraded by Zacks. The firm has “Outperform” rating given on Wednesday, September 28 by WestPark Capital. The firm earned “Hold” rating on Friday, August 5 by Craig Hallum.

Investors sentiment increased to 1.14 in Q2 2017. Its up 0.64, from 0.5 in 2017Q1. It increased, as 1 investors sold Research Frontiers, Inc. shares while 6 reduced holdings. 4 funds opened positions while 4 raised stakes. 4.20 million shares or 10.52% less from 4.70 million shares in 2017Q1 were reported. Wells Fargo Mn has 0% invested in Research Frontiers, Inc. (NASDAQ:REFR). 36,000 are owned by Outfitter Advisors Ltd. Homrich And Berg invested 0% in Research Frontiers, Inc. (NASDAQ:REFR). Moreover, Tower Research Cap Ltd Limited Liability Company (Trc) has 0% invested in Research Frontiers, Inc. (NASDAQ:REFR) for 2,546 shares. Blackrock stated it has 710,455 shares. State Bank Of America De has invested 0% of its portfolio in Research Frontiers, Inc. (NASDAQ:REFR). Vanguard Grp Inc Inc owns 557,929 shares or 0% of their US portfolio. Raymond James Associates holds 0% or 27,500 shares. Geode Cap Mgmt Limited Co reported 95,951 shares. Goldman Capital Management reported 2.09M shares or 2.86% of all its holdings. Gru One Trading Ltd Partnership accumulated 8,375 shares. United Advisers Ltd Limited Liability Company has 0% invested in Research Frontiers, Inc. (NASDAQ:REFR). Connors Investor Services Inc reported 124,146 shares. Stephens Ar has invested 0% in Research Frontiers, Inc. (NASDAQ:REFR). Morgan Stanley invested in 0% or 10,898 shares.

Analysts await Research Frontiers, Inc. (NASDAQ:REFR) to report earnings on March, 12. They expect $-0.03 EPS, up 50.00% or $0.03 from last year’s $-0.06 per share. After $-0.01 actual EPS reported by Research Frontiers, Inc. for the previous quarter, Wall Street now forecasts 200.00% negative EPS growth.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>